Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the KSA.
Campus
Campus

T1D Treatment Practice and the SAGE Study

Lori Berard, Nurse Consultant, Diabetes Educator from Winnipeg, MB, Canada shares insights about unmet needs for T1D patients as well as reflects on the SAGE study presentations during ATTD 2021.

Related articles
Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens

Advancing Therapy with iGlarLixi: Differentiation from complex insulin regimens

An educational video outlining key data from indirect comparisons of iGlarLixi versus IDegAsp.

Read article
Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

Advancing Therapy with iGlarLixi: Differentiation from other complex regimens

Read article
Treatment simplification of complex insulin regimens in T2D

Treatment simplification of complex insulin regimens in T2D

An educational video to discuss the challenges associated with commonly-used insulin advancement options and the need for treatment simplification for many adults with T2D. The video reviews data supporting the use of BI + GLP-1 RA FRCs versus commonly-used insulin regimens in adults with T2D.

Read article
MAT-BH-2300622/v1/November 2023